Nebraska Medicine

[3] The company operates the largest of only four dedicated biocontainment units in the United States,[4] and is particularly recognized for programs in fields such as organ transplantation,[5] cancer treatment, gastroenterology, neurology, neurosurgery, COPD, heart bypass surgery, heart failure treatment, and hip replacement.

[3] Nebraska Medicine was named one of the best hospitals in U.S. News & World Report’s 2008 publication for Cancer and Neurology & Neurosurgery.

[15] In 2016, Nebraska Medicine finished an expansion of its Village Pointe location, expanding on an outpatient surgery center and clinics.

[16] Nebraska Medicine paid $130 million in January 2016 to fully purchase Bellevue Medical Center, which it had previously been leasing.

[17] In February 2016, Nebraska Medicine reached Stage 7 on the Electronic Medical Record Adoption Model (EMRAM) developed by HIMSS Analytics.

[11] In 2016, Nebraska Medicine finished an expansion of its Village Pointe location, expanding on an outpatient surgery center and clinics.

That May, Nebraska Medicine opened the Fred & Pamela Buffett Cancer Center, a partly public partnership with various state and county investors.

[23] Nebraska Medicine and UNMC sent a team of infectious disease experts to Uganda in September 2018 to train local healthcare workers.

Nebraska Medicine had previously provided regional laboratory services to local hospitals, since 1998, also maintaining related records.

[28] By 2019, some Nebraska Medicine hospital rooms featured virtual reality headsets to teach patients about procedures.

[34] During the early stages of the COVID-19 pandemic, in February 2020, Nebraska Medicine partnered with the federal government to evacuate Americans in Wuhan, China.

[35][36][37] 57 evacuees were quarantined in Camp Ashland,[36][37] with Nebraska Medicine on standby to treat patients who developed symptoms.

[38] Later that month, Nebraska Medicine was involved in training personnel and then testing and transporting American evacuees from the Diamond Princess cruise ship in Japan.

[43] Performing a study in both units,[43] Nebraska Medicine found high levels of the virus on surfaces and in the air of rooms of COVID-19 patients, providing "evidence that the disease might spread by both direct contact, as well as indirect contact, such as touching a contaminated object, or contracting the virus through airborne transmission"[45] as an aerosol.

[47] On March 12, 2020, all Nebraska Medicine-related travel for faculty, providers, and students was suspended immediately to "slow the progression of COVID-19 in our community and protect our patients, families and each other from infection with COVID-19," with the policy to be reassessed every one to two months.

[54] The Nebraska Medical Center in April 2020[56] also began using the Infectious Aerosol Capture Mask, which was developed by UNMC to contain particles released by patients in operating and recovery rooms.

Additional facilities in Omaha include nine outpatient clinics, Nebraska Orthopaedic Hospital and Bellevue Medical Center company has 809 licensed beds.

[3] The company operates the largest of only four dedicated biocontainment units in the United States,[4] and is particularly recognized for programs in fields such as organ transplantation[5] cancer treatment, gastroenterology, neurology, neurosurgery, COPD, heart bypass surgery, heart failure treatment, and hip replacement.

A number of buildings on the Nebraska Medical Center campus are operated by UNMC, for example the Eppley Cancer Institute.